Management strategies in unstable coronary artery disease-Current problems and future directions Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Unstable coronary artery disease continues to pose a major challenge to clinicians. The advent of new therapies, such as percutaneous transluminal coronary angioplasty, low-molecular-weight heparins, and glycoprotein IIb/IIIa inhibitors, provides new management options for this indication but also raises new questions with regard to optimal management. Prospective randomized trials with well-defined, long-term outcome measures and a means of identifying which patients will derive most benefit from each treatment, together with a means of rapid and clear dissemination of study results and implications, are required in order to advance the management of unstable coronary artery disease.

authors

  • Verheugt, FWA
  • Becker, RC
  • Bertrand, ME
  • Bode, C
  • Chesebro, JH
  • Cleland, JGF
  • Conti, R
  • Hillis, WS
  • Klein, W
  • Maseri, A
  • Turpie, Alexander Graham Gri
  • Wallentin, L
  • Waters, DD

publication date

  • September 1999